A detailed history of Forbes J M & CO LLP transactions in Beyond Air, Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 35,020 shares of XAIR stock, worth $19,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,020
Previous 35,020 -0.0%
Holding current value
$19,961
Previous $18,000 27.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$4.96 - $7.83 $43,127 - $68,081
8,695 Added 33.03%
35,020 $234,000
Q2 2021

Aug 03, 2021

BUY
$4.72 - $7.15 $42,008 - $63,635
8,900 Added 51.08%
26,325 $171,000
Q2 2020

Aug 07, 2020

BUY
$6.44 - $9.45 $41,860 - $61,424
6,500 Added 59.5%
17,425 $126,000
Q1 2020

May 15, 2020

BUY
$3.94 - $10.93 $43,044 - $119,410
10,925 New
10,925 $87,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Forbes J M & CO LLP Portfolio

Follow Forbes J M & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.